mRNA Gene Therapy: Early Phase Development

By QPS

While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19 vaccines has expanded interest in the field Despite manufacturers like Sanofi announcing significant investment and intent to become an active participant in developing mRNA-based therapies, there are still some challenges that researchers will need to overcome to realize the full potential of mRNA therapies.